OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $297,986 Invested

2024

University College London

Simon Mead, MD, FRCP, PhD

Biomarker-driven phenotyping for Alzheimer's disease and related dementia

  • Funding Amount: $297,986
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Active